Patents by Inventor William Dow

William Dow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240109915
    Abstract: A compound having the structures: or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, wherein; R selected from the group consisting of H, C1-C6 alkyl, C1-C6 alkoxy and —(CH2)m—W, where W is C3-C8 cycloalkyl, bicycloalkyl, bridged bicycloalkyl, phenyl, 5- or 6-membered heteroaryl or heterocyclic containing one, two or three heteroatoms selected from the group consisting of N, S and O atoms; wherein each of said alkyl, cycloalkyl, alkoxy, heterocyclic, phenyl, naphthyl or heteroaryl may be unsubstituted or substituted by phenyl, halo, cyano, deuterium, hydroxy, C1-C6 alkyl, C1-C6 alkoxy, —SO2—R?, —CONR?R?, NR?COR?, —NR?CONR?R?, —NR?CO2R?, —(CH2)n—SO2—R?, —NHSO2—R?, —NR?SO2—R?, —SO2NR?R?, NR?R? or SR? where R? and R? are independently H, C1-C6 alkyl or C3-C8 cycloalkyl; R1 selected from the group consisting of phenyl, naphthyl, 5- or 6-membered heteroaryl or heterocyclic containing one, two, three or four heteroatoms se
    Type: Application
    Filed: July 26, 2023
    Publication date: April 4, 2024
    Applicant: Pfizer Inc.
    Inventors: Scott William Bagley, Andrea Nicole Bootsma, Chulho Choi, Robert Lee Dow, David James Edmonds, Carmen Noemi Garcia-Irizarry, Brian Stephen Gerstenberger, Gajendra Ingle, Jessica Gloria Katherine O'Brien, Mihir Dineshkumar Parikh, Gwenaella Christine Rescourio, Daniel Copley Schmitt
  • Patent number: 10101050
    Abstract: A thermostat management server may include one or more processors and one or more memory devices comprising instructions that, when executed by the one or more processors, cause the one or more processors to perform operations comprising receiving information that characterizes energy usage associated with the plurality of thermostats, receiving parameters characterizing proposed future demand-response events, selecting a combination of thermostats from the plurality of thermostats for which the energy usage can be reduced, simulating a demand response event based on the parameters and using different weather conditions for the combination of the plurality of thermostats, generating statistical probabilities of meeting a plurality of capacity reduction levels based on the different weather conditions, selecting a capacity reduction level from the plurality of capacity reduction levels based on the statistical probabilities, and sending the capacity reduction level to the utility provider computer system.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: October 16, 2018
    Assignee: Google LLC
    Inventors: Ana Radovanovic, William Dow Heavlin, Wolf-Dietrich Weber, Ankit Somani, Seungil You, Matthew Wytock
  • Publication number: 20170167742
    Abstract: A thermostat management server may include one or more processors and one or more memory devices comprising instructions that, when executed by the one or more processors, cause the one or more processors to perform operations comprising receiving information that characterizes energy usage associated with the plurality of thermostats, receiving parameters characterizing proposed future demand-response events, selecting a combination of thermostats from the plurality of thermostats for which the energy usage can be reduced, simulating a demand response event based on the parameters and using different weather conditions for the combination of the plurality of thermostats, generating statistical probabilities of meeting a plurality of capacity reduction levels based on the different weather conditions, selecting a capacity reduction level from the plurality of capacity reduction levels based on the statistical probabilities, and sending the capacity reduction level to the utility provider computer system.
    Type: Application
    Filed: December 9, 2016
    Publication date: June 15, 2017
    Applicant: Google Inc.
    Inventors: Ana Radovanovic, William Dow Heavlin, Wolf-Dietrich Weber, Ankit Somani, Seungil You, Matthew Wytock
  • Patent number: 8343463
    Abstract: The near-infrared wavelengths (700 nm-900 nm) are a suitable optical window for light penetration and deep tissue imaging. The present invention provides a near-infrared fluorescent blood pool contrast agent. The agent is of use to detect and quantify pathological capillary leak in live animals, e.g., serially imaging of traumatized tissue (muscle) as well as tumors.
    Type: Grant
    Filed: August 2, 2010
    Date of Patent: January 1, 2013
    Assignee: Numira Biosciences Inc.
    Inventors: William Dow, Karen B. Dow, legal representative
  • Publication number: 20110027191
    Abstract: The near-infrared wavelengths (700 nm-900 nm) are a suitable optical window for light penetration and deep tissue imaging. The present invention provides a near-infrared fluorescent blood pool contrast agent. The agent is of use to detect and quantify pathological capillary leak in live animals, e.g., serially imaging of traumatized tissue (muscle) as well as tumors.
    Type: Application
    Filed: August 2, 2010
    Publication date: February 3, 2011
    Applicant: Numira Biosciences, Inc.
    Inventors: William DOW, Karen B. Dow
  • Patent number: 7360565
    Abstract: A fuel overflow prevention device for minimizing or eliminating fuel spillage during fuel storage container filling. The device may also minimize or eliminate some types of fuel spillage after filling. The device includes an overflow prevention chamber for receiving therein fluid from a fuel storage container vent tube. The overflow prevention chamber also includes a space for removably receiving and retaining therein the spout of an automatic shutoff fuel nozzle including a sensor port. A flow restriction interface is established between an interior portion of the overflow prevention chamber and the exit port of the spout. Fluid received from the vent tube into the overflow prevention chamber fills the space until covering the sensor port to a level sufficient to trigger automatic nozzle shutoff. The device optionally includes a vent tube extension to aid in regulating the fuel level within the container at which nozzle shutoff is triggered.
    Type: Grant
    Filed: June 20, 2006
    Date of Patent: April 22, 2008
    Assignee: University of Maine System
    Inventors: Michael Peterson, Stephen Ergmann, Stefan Scarks, William Dow
  • Publication number: 20070289664
    Abstract: A fuel overflow prevention device for minimizing or eliminating fuel spillage during fuel storage container filling. The device may also minimize or eliminate some types of fuel spillage after filling. The device includes an overflow prevention chamber for receiving therein fluid from a fuel storage container vent tube. The overflow prevention chamber also includes a space for removably receiving and retaining therein the spout of an automatic shutoff fuel nozzle including a sensor port. A flow restriction interface is established between an interior portion of the overflow prevention chamber and the exit port of the spout. Fluid received from the vent tube into the overflow prevention chamber fills the space until covering the sensor port to a level sufficient to trigger automatic nozzle shutoff. The device optionally includes a vent tube extension to aid in regulating the fuel level within the container at which nozzle shutoff is triggered.
    Type: Application
    Filed: June 20, 2006
    Publication date: December 20, 2007
    Applicant: University of Maine System
    Inventors: Michael Peterson, Stephen Ergmann, Stefan Scarks, William Dow
  • Publication number: 20050232866
    Abstract: The present invention provides a class of biochemically-activated MRI contrast agents. The agents include a paramagnetic chelate attached via a linker arm to a relaxivity-modulating group. When the relaxivity-modulating group is removed or otherwise interacts with a targeted substance, the agents are activated by various mechanisms. The activation is detectable by an increase or decrease in the relaxivity of the metal chelate. The agents are useful in the detection of biochemical parameters in cells, tissues and subjects. Exemplary biochemical parameters are markers that are associated with disease states.
    Type: Application
    Filed: March 25, 2005
    Publication date: October 20, 2005
    Applicant: Alerion Biomedical Inc.
    Inventors: Marco Melchior, Ying You, Serguei Calugaru, William Dow